MedPath

Naproxen

Naproxen Tablets, USP

Approved
Approval ID

5e802e0f-8f76-499e-9448-2c9fb8cab96b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 23, 2012

Manufacturers
FDA

Life Line Home Care Services, Inc.

DUNS: 844985374

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naproxen

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code75921-190
Application NumberANDA075927
Product Classification
M
Marketing Category
C73584
G
Generic Name
Naproxen
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 23, 2012
FDA Product Classification

INGREDIENTS (4)

NAPROXENActive
Quantity: 500 mg in 1 1
Code: 57Y76R9ATQ
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Naproxen - FDA Drug Approval Details